RT Journal Article
SR Electronic
T1 A Novel Triage Tool of Artificial Intelligence Assisted Diagnosis Aid System for Suspected COVID-19 pneumonia In Fever Clinics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.19.20039099
DO 10.1101/2020.03.19.20039099
A1 Feng, Cong
A1 Huang, Zhi
A1 Wang, Lili
A1 Chen, Xin
A1 Zhai, Yongzhi
A1 Zhu, Feng
A1 Chen, Hua
A1 Wang, Yingchan
A1 Su, Xiangzheng
A1 Huang, Sai
A1 Tian, Lin
A1 Zhu, Weixiu
A1 Sun, Wenzheng
A1 Zhang, Liping
A1 Han, Qingru
A1 Zhang, Juan
A1 Pan, Fei
A1 Chen, Li
A1 Zhu, Zhihong
A1 Xiao, Hongju
A1 Liu, Yu
A1 Liu, Gang
A1 Chen, Wei
A1 Li, Tanshi
YR 2020
UL http://medrxiv.org/content/early/2020/03/20/2020.03.19.20039099.abstract
AB Currently, the prevention and control of COVID-19 outside Hubei province in China, and other countries has become more and more critically serious. We developed and validated a diagnosis aid model without CT images for early identification of suspected COVID-19 pneumonia (S-COVID-19-P) on admission in adult fever patients and made the validated model available via an online triage calculator. Patients admitted from Jan 14 to Feb 26, 2020 with the epidemiological history of exposure to COVID-19 were included [Model development (n = 132) and validation (n = 32)]. Candidate features included clinical symptoms, routine laboratory tests and other clinical information on admission. Features selection and model development were based on Lasso regression. The primary outcome is the development and validation of a diagnosis aid model for S-COVID-19-P early identification on admission. The development cohort contains 26 S-COVID-19-P and 7 confirmed COVID-19 pneumonia cases. The model performance in held-out testing set and validation cohort resulted in AUCs of 0.841 and 0.938, F-1 score of 0.571 and 0.667, recall of 1.000 and 1.000, specificity of 0.727 and 0.778, and the precision of 0.400 and 0.500. Based on this model, an optimized strategy for S-COVID-19-P early identification in fever clinics has also been designed. S-COVID-19-P could be identified early by a machine-learning model only used collected clinical information without CT images on admission in fever clinics with 100% recall score. The well performed and validated model has been deployed as an online triage tool, which is available at: https://intensivecare.shinyapps.io/COVID19/.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNOAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author on reasonable request. Participant data without names and identifiers will be made available after approval from the corresponding author, PLAGH and National Health Commission. After publication of study findings, the data will be available for others to request. The research team will provide an email address for communication once the data are approved to be shared with others. The proposal with detailed description of study objectives and statistical analysis plan will be needed for evaluation of the reasonability to request for our data. The corresponding author, PLAGH and National Health Commission will make a decision based on these materials. Additional materials may also be required during the process.